Amylin Revisited: A 5-Year Perspective on Its Emerging Role in the Treatment of Diabesity
Amylin is a pancreatic peptide hormone that regulates blood glucose levels and appetite. This review outlines the physiological role of amylin and highlights recent clinical studies exploring its therapeutic potential in diabetes and obesity. Amylin lowers postprandial glucose levels by delaying gas...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Society for the Study of Obesity
2026-01-01
|
| סדרה: | Journal of Obesity & Metabolic Syndrome |
| נושאים: | |
| גישה מקוונת: | http://www.jomes.org/journal/view.html?doi=10.7570/jomes25085 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|